Paul Casaz, Ph.D.
Director, Formulation and Characterization
Paul Casaz is Director, Formulation and Characterization at Verve Therapeutics, where he leads analytical development and characterization for guide RNA, mRNA and LNPs. Dr. Casaz has extensive experience in analytical development and formulation for monoclonal antibodies, gene therapy vectors and gene editing reagents. Prior to Verve, Paul worked at BlueRock Therapeutics, where he helped to establish their CRISPR off-target analysis platform. Prior to that, Paul worked at Casebia Therapeutics, where he led analytical development for AAV vectors that express CRISPR nucleases and guide RNA. Paul has a Ph.D. in Virology from Harvard and a B.S. in Bacteriology from the University of Wisconsin.